Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company is expected to reach a profit turning point, with performance exceeding market expectations. The forecast for 2025 indicates a significant recovery in profitability, with a projected net profit of 137.22 million yuan, a year-on-year increase of 124.67% [1][7] - The company anticipates a substantial increase in membrane shipments, with Q4 2025 expected to exceed 35 billion square meters, representing a year-on-year growth of over 70% [7] - The company is actively expanding its product offerings, including lithium sulfide and solid-state electrolyte products, which are positioned to lead in performance metrics within the industry [7] Financial Forecasts - Total revenue is projected to be 13,602 million yuan in 2025, reflecting a year-on-year growth of 33.83% [1] - The net profit attributable to shareholders is forecasted to be 137.22 million yuan in 2025, with significant growth expected in subsequent years, reaching 2,536.42 million yuan in 2026 and 3,149.25 million yuan in 2027 [1][8] - The earnings per share (EPS) is expected to recover to 0.14 yuan in 2025, with further increases to 2.58 yuan in 2026 and 3.21 yuan in 2027 [1][8] Market Data - The closing price of the company's stock is 48.65 yuan, with a market capitalization of approximately 47.79 billion yuan [5] - The company has a price-to-earnings (P/E) ratio of 348.24 for 2025, which is expected to decrease to 18.84 in 2026 and 15.17 in 2027 [1][8]
恩捷股份:2025年业绩预告点评:盈利拐点已至,业绩超市场预期-20260131